Nine Masts Capital »

Fate Therapeutics shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $19k 19k 0.98

More positions owned by Nine Masts Capital

Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Norfolk Southern (NSC)
Fox Corp Cl B Com (FOX)
Invesco Qqq Tr Unit Ser 1 (Principal) (QQQ)
Cyberark Software SHS (CYBR)
Nio Note 4.625%10/1 (Principal)
Qorvo (QRVO)
Ase Technology Hldg Sponsored Ads (ASX)
GSK Sponsored Adr (GSK)
Zillow Group Cl C Cap Stk (Z)
EXACT Sciences Corporation (EXAS)
Ryanair Holdings Sponsored Adr (RYAAY)
Jd.com Spon Ads Cl A (JD)

View all positions for Nine Masts Capital

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Vestal Point Capital
Dimensional Fund Advisors
Point72 Asset Management
Goldman Sachs Group
Tang Capital Management
AQR Capital Management

View all funds holding Fate Therapeutics